title: Reply: To PMID 24999724.
authors.affiliation: *Department of Ophthalmology, Scientific Institute San Raffaele, University Vita-Salute, Milano, Italy †G. B. Bietti Foundation for Study and Research in Ophthalmology, IRCCS, Rome, Italy.
authors.forename: Maurizio Battaglia
authors.initials: MB
authors.lastname: Parodi
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Iacono
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D000069579:Ranibizumab; D057135:Wet Macular Degeneration / Q000150:complications*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab